LCG
CRNX icon

Lisanti Capital Growth’s Crinetics Pharmaceuticals CRNX Stock Holding History

Lisanti Capital Growth’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-43,040
Closed -$2M – 119
2025
Q4 		$2M Buy
43,040
+20,150
+88% +$897K 0.47% 83
2025
Q3 		$953K Buy
+22,890
New +$732K 0.23% 93
2025
Q1 		– Sell
-82,700
Closed -$4.23M – 120
2024
Q4 		$4.23M Sell
82,700
-25,875
-24% -$1.45M 1.02% 40
2024
Q3 		$5.55M Buy
108,575
+25,195
+30% +$1.3M 1.41% 18
2024
Q2 		$3.73M Buy
83,380
+14,155
+20% +$654K 0.9% 56
2024
Q1 		$3.24M Sell
69,225
-31,020
-31% -$1.21M 0.79% 61
2023
Q4 		$3.57M Buy
100,245
+50,265
+101% +$1.54M 0.84% 56
2023
Q3 		$1.49M Buy
+49,980
New +$1.03M 0.23% 109

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return